Literature DB >> 28191604

Dual Immunohistochemical Detection of Mitoses in Melanoma.

Thomas M Soike1, John C Maize2, Jonathan S Ralston2, Benjamin Hayes2, Julie Swick2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28191604     DOI： 10.1007/s12253-017-0203-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN： 1219-4956            Impact factor:   3.201


× No keyword cloud information.
  12 in total

1.  Analysis of tumor mitotic rate in thin metastatic melanomas compared with thin melanomas without metastasis using both the hematoxylin and eosin and anti-phosphohistone 3 IHC stain.

Authors:  Sumeet Thareja; Jonathan S Zager; Divya Sadhwani; Shalini Thareja; Ren Chen; Suroosh Marzban; Drazen M Jukic; Lewis F Glass; Jane Messina
Journal:  Am J Dermatopathol       Date:  2014-01       Impact factor: 1.533

2.  Cell cycle-dependent suppressive effect of histone H1 on mitosis-specific H3 phosphorylation.

Authors:  K Shibata; K Ajiro
Journal:  J Biol Chem       Date:  1993-09-05       Impact factor: 5.157

3.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

4.  Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation.

Authors:  M J Hendzel; Y Wei; M A Mancini; A Van Hooser; T Ranalli; B R Brinkley; D P Bazett-Jones; C D Allis
Journal:  Chromosoma       Date:  1997-11       Impact factor: 4.316

5.  Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.

Authors:  Susan B Kesmodel; Giorgos C Karakousis; Jeffrey D Botbyl; Robert J Canter; Robert T Lewis; Peter M Wahl; Kyla P Terhune; Abass Alavi; David E Elder; Michael E Ming; DuPont Guerry; Phyllis A Gimotty; Douglas L Fraker; Brian J Czerniecki; Francis R Spitz
Journal:  Ann Surg Oncol       Date:  2005-04-19       Impact factor: 5.344

6.  Mitotic rate in melanoma: prognostic value of immunostaining and computer-assisted image analysis.

Authors:  Christopher S Hale; Meng Qian; Michelle W Ma; Patrick Scanlon; Russell S Berman; Richard L Shapiro; Anna C Pavlick; Yongzhao Shao; David Polsky; Iman Osman; Farbod Darvishian
Journal:  Am J Surg Pathol       Date:  2013-06       Impact factor: 6.394

7.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Authors:  C M Balch; S J Soong; J E Gershenwald; J F Thompson; D S Reintgen; N Cascinelli; M Urist; K M McMasters; M I Ross; J M Kirkwood; M B Atkins; J A Thompson; D G Coit; D Byrd; R Desmond; Y Zhang; P Y Liu; G H Lyman; A Morabito
Journal:  J Clin Oncol       Date:  2001-08-15       Impact factor: 44.544

8.  Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.

Authors:  Y Kawakami; S Eliyahu; C H Delgado; P F Robbins; L Rivoltini; S L Topalian; T Miki; S A Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma.

Authors:  Michael T Tetzlaff; Jonathan L Curry; Doina Ivan; Wei-Lien Wang; Carlos A Torres-Cabala; Roland L Bassett; Karla M Valencia; Michael S McLemore; Merrick I Ross; Victor G Prieto
Journal:  Mod Pathol       Date:  2013-04-05       Impact factor: 7.842

10.  Immunohistochemical dual staining as an adjunct in assessment of mitotic activity in melanoma.

Authors:  Kristian Ikenberg; Madeleine Pfaltz; Christiane Rakozy; Werner Kempf
Journal:  J Cutan Pathol       Date:  2012-03       Impact factor: 1.587
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.